Croda International Plc announce the appointment of Nawal Ouzren as non-executive director. Nawal will join the Board with effect from 1 February 2022. Nawal has 20 years of expertise across a wide range of business roles, including clinical development, operational and strategic management roles within the pharmaceutical industry.

Nawal currently serves as CEO at Sensorion, a Euronext listed biopharmaceutical company headquartered in France. On joining the Croda Board, Nawal will also be appointed to the Audit, Nomination and Remuneration Committees.